Predicting efficacy of drug-carrier nanoparticle designs for cancer treatment: a machine learning-based solution

In this section, we discuss the data used for this study, the technical transformation, and the proposed models in detail. This study did not require ethical approval. data description The data we use in the project are derived from MD simulations which are generated using AMBER19 software54. In these simulations, the initial energy of the …

Predicting efficacy of drug-carrier nanoparticle designs for cancer treatment: a machine learning-based solution Read More »